Lead Product(s) : Dermatophagoides Farinae
Therapeutic Area : Dermatology
Study Phase : Phase II
Sponsor : Tongji Hospital | First Affiliated Hospital of Suzhou Medical College | Wolwo Bio-pharmaceutical Co. LTD. | Huashan Hospital | Xinhua Hospital, Shanghai Jiaotong University School of Medicine | Peking University Third Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Sublingual Immunotherapy in Patients With Atopic Dermatitis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
November 11, 2011
Lead Product(s) : Dermatophagoides Farinae
Therapeutic Area : Dermatology
Highest Development Status : Phase II
Sponsor : Tongji Hospital | First Affiliated Hospital of Suzhou Medical College | Wolwo Bio-pharmaceutical Co. LTD. | Huashan Hospital | Xinhua Hospital, Shanghai Jiaotong University School of Medicine | Peking University Third Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable